Questionnaire and Radiography for Prosthesis Follow-up (Follow-up)

April 6, 2020 updated by: University Hospital, Clermont-Ferrand

Evaluation of a New Long-term Total Articular Prosthesis Follow-up Strategy by Simple Questionnaire and Radiography

Ever-evolving prosthetic activity as described in a Swedish study that predicts 469 TKA per 10,000 inhabitants in 2130. Increased consultation of controls and post-arthroplasty follow-up is expected. There is a legal obligation to ensure long-term follow-up without official recommendation on follow-up procedures. The objective is to compare a consultation + Xray by the surgeon versus an Xray and a questionnaire completed by the patient who had a knee or hip replacement. This is to demonstrate the equivalence of both.

All patients who come back for an annual check of a prosthesis should complete this questionnaire and perform an X-ray of their prosthesis. The study lasts one year and includes all the patients with a previous knee or hip arthroplasty.

The result of the questionnaire and Xray will be compared to that of the consultation and Xray.

Study Overview

Detailed Description

An english study published an article showing that a follow up by questionnaire versus a consultation was also effective.

For this study, investigator is going to take back all the patients having to return to consultation in 2017. . Normally at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.

Thus investigator will be able to see the number of patients seen in consultation compared to the theoretical number The purpose of this study is to highlight the non-inferiority of the questionnaire compared to the consultation for screening for complications at 10 years.

If this proves to be the case, only complicating patients could be reviewed by calling them to the radio and their questionnaire.

Study Type

Observational

Enrollment (Actual)

656

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • CHU Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who have had a primary total hip or total knee arthroplasty that must be seen again in 2017

Description

Inclusion Criteria:

  • Patients who have had a primary total hip or total knee arthroplasty that must be seen again in 2017. Normally at 3 months, 1 years, 3, 5, 10, 15 and 20 years post-operatively

Exclusion Criteria:

  • Patients who have previous complications with their joint replacement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1
a new long-term total articular prosthesis follow-up strategy by simple questionnaire and radiography (questionnaire and Xray for all patients)
questionnaire and Xray for all patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 3 months
Feasibility study of a new strategy of follow-up by questionnaire
at 3 months
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 1year
Feasibility study of a new strategy of follow-up by questionnaire
at 1year
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 3 years
Feasibility study of a new strategy of follow-up by questionnaire
at 3 years
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 5 years
Feasibility study of a new strategy of follow-up by questionnaire
at 5 years
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 10 years
Feasibility study of a new strategy of follow-up by questionnaire
at 10 years
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 15 years
Feasibility study of a new strategy of follow-up by questionnaire
at 15 years
Patients seen in consultation follow-up or not (yes / no).
Time Frame: at 20 years
Feasibility study of a new strategy of follow-up by questionnaire
at 20 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
economic impact (Number of working day)
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
Number of working day in days
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
economic impact (Number of consultations)
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
Number of consultations with the surgeon,
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
economic impact (Number of radiography)
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
Number of radiography realized by the patient
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
economic impact (Cost phone call)
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
According to the number of realized phone call
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
Evaluation of the feasibility of the questionnaire for detection of certain complications
Time Frame: at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.
Evaluation of the feasibility of the questionnaire method
at 3 months, 1, 3, 5, 10, 15 and 20 years post-operatively.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Roger ERIVAN, University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2018

Primary Completion (Actual)

October 30, 2019

Study Completion (Actual)

October 30, 2019

Study Registration Dates

First Submitted

October 19, 2018

First Submitted That Met QC Criteria

November 16, 2018

First Posted (Actual)

November 19, 2018

Study Record Updates

Last Update Posted (Actual)

April 7, 2020

Last Update Submitted That Met QC Criteria

April 6, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • CHU-412
  • 2018-A01022-53 (Other Identifier: 2018-A01022-53)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip and Knee Arthroplasties

Clinical Trials on questionnaire and Xray for all patients

3
Subscribe